Publication:
Testing Susceptibility of Multidrug-Resistant Mycobacterium tuberculosis to Second-Line Drugs by Use of Blood Agar

Simple item page
dc.authorscopusid8888312500
dc.authorscopusid7007135107
dc.authorscopusid8888312400
dc.contributor.authorŞatana, D.
dc.contributor.authorÇoban, A.Y.
dc.contributor.authorUzun, M.
dc.date.accessioned2020-06-21T14:46:50Z
dc.date.available2020-06-21T14:46:50Z
dc.date.issued2010
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Şatana] Dilek, Department of Microbiology and Clinical Microbiology, İstanbul Tıp Fakültesi, Istanbul, Turkey; [Çoban] Ahmet Yilmaz, Department of Microbiology and Clinical Microbiology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Uzun] Meltem Önder, Department of Microbiology and Clinical Microbiology, İstanbul Tıp Fakültesi, Istanbul, Turkeyen_US
dc.description.abstractIn this study, the susceptibilities of 35 multidrug-resistant (MDR) Mycobacterium tuberculosis clinical isolates to second-line drugs, including kanamycin (KM), rifabutin (RBU), ofloxacin (OFX), p-aminosalicylic acid (PAS), capreomycin (CAP), clofazimine (CFM), and ethionamide (ETH), were investigated on blood agar according to CLSI recommendations. Compared with the results of the Bactec 460 TB system, agreement was 100, 100, 97, 100, 100, 100, and 86% for KM, RBU, OFX, PAS, CAP, CFM, and ETH, respectively. Compared with the results of the proportion method, agreement was 100, 100, 97, 100, 97, 100, and 77% for KM, RBU, OFX, PAS, CAP, CFM, and ETH, respectively. Copyright © 2010, American Society for Microbiology. All Rights Reserved.en_US
dc.identifier.doi10.1128/JCM.00688-10
dc.identifier.endpage4293en_US
dc.identifier.issn0095-1137
dc.identifier.issue11en_US
dc.identifier.pmid20826642
dc.identifier.scopus2-s2.0-78049494008
dc.identifier.scopusqualityQ1
dc.identifier.startpage4291en_US
dc.identifier.urihttps://doi.org/10.1128/JCM.00688-10
dc.identifier.volume48en_US
dc.identifier.wosWOS:000283588500075
dc.identifier.wosqualityQ1
dc.language.isoenen_US
dc.publisherAmer Soc Microbiologyen_US
dc.relation.ispartofJournal of Clinical Microbiologyen_US
dc.relation.journalJournal of Clinical Microbiologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleTesting Susceptibility of Multidrug-Resistant Mycobacterium tuberculosis to Second-Line Drugs by Use of Blood Agaren_US
dc.typeArticleen_US
dspace.entity.typePublication

Files

Collections

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu